These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8774671)

  • 1. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N; Høier-Madsen M; Kangro H
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
    Portet Sulla V; Kadi A; Mouna L; Fenaux H; Cechura H; Rafek R; Di Ciccone JL; Warnakulasuriya F; Vauloup-Fellous C
    J Virol Methods; 2024 Sep; 329():115002. PubMed ID: 39067186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
    Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
    Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
    Andersson A; Vetter V; Kreutzer L; Bauer G
    J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.
    Guerrero-Ramos A; Patel M; Kadakia K; Haque T
    Clin Vaccine Immunol; 2014 Jun; 21(6):817-23. PubMed ID: 24695777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections.
    O'Neill HJ; Shirodaria PV
    J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A; Andersson J; Lundgren G; Wahren B
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
    Ternák G; Szúcs G; Uj M
    Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
    Debyser Z; Reynders M; Goubau P; Desmyter J
    Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.